HB 197 appropriates $25 million annually for the 2025-2026 and 2026-2027 fiscal years to North Carolina's local health departments (LHDs) for communicable disease programs. The funding aims to address a 70% staff shortage in LHDs by enabling them to retain existing staff, hire additional public health professionals (including nurses), and expand essential services. Funds are allocated with half distributed equally among LHDs based on the number of counties served, and half distributed based on the percentage of state population each LHD serves. The bill becomes effective July 1, 2025, to support North Carolina's response to diseases like avian flu and mpox.
HB 351 establishes North Carolina's Recovery-Friendly Workplace Program, which helps employers support employees in addiction recovery. Employers (both public and private) can become "participants" or earn "certified" status by completing training, adopting inclusive policies (like flexible leave and confidential treatment access), and implementing evidence-based practices. The program, funded with $300,000 from the Opioid Settlement Fund, provides employers with advisors, model policies, and annual reviews to maintain certification. It directly affects all North Carolina employers covered by workers' compensation and their employees seeking recovery support. The program becomes effective July 1, 2025.
HB 54 allocates $125,000 annually from the General Fund (2025-2027) to fund training programs developed by the NC Association of People Supporting Employment First (NC APSE). The training, delivered via online modules, will help employers, service providers, and other entities support individuals with serious mental illness, intellectual disabilities, or developmental disabilities in finding and keeping competitive jobs. It focuses on evidence-based supported employment practices to improve job placement and retention. The bill directly affects individuals with these disabilities and the organizations that serve them, with training available statewide starting July 1, 2025.
HB 75, the Pharmaceutical Full Disclosure Act, requires prescription drug manufacturers to clearly disclose specific information in advertisements targeting North Carolina consumers. It mandates that ads include the FDA approval date for the drug's use, the date the drug first became available to U.S. consumers, and detailed clinical trial data for required side effects (such as trial length, participant numbers, and side effect frequency). The law applies to all advertisements via TV, internet, print, or radio in North Carolina published on or after October 1, 2025, directly affecting drug manufacturers and their marketing materials. This policy change aims to provide clearer, evidence-based information about prescription drugs in promotional content.
HB 76, titled "Protect Access to Assisted Reproductive Technology," establishes legal protections for patients and healthcare providers regarding fertility treatments. The bill prohibits North Carolina or its local governments from banning, unreasonably limiting, or interfering with patients' access to assisted reproductive technology (ART) - including in vitro fertilization (IVF) - or healthcare providers' ability to offer evidence-based information or perform ART services. Key provisions define "assisted reproductive technology" broadly and clarify that the law does not override existing health and safety regulations for medical facilities. This directly affects individuals seeking fertility care and healthcare providers offering such services within North Carolina. The bill does not create new funding or services but ensures state-level barriers cannot restrict access to these medical treatments.
SB 82 establishes a multi-state compact (the "Solemn Covenant of States") to create a commission that awards prizes for scientifically validated disease cures. It would require at least six states to join before forming the commission, which would review and fund cures, then make them widely available at prices covering only manufacturing and distribution costs. Non-participating states would pay royalties based on estimated public health savings, with funds used to cover prize costs and refunded to joining states. The bill directly affects participating states' taxpayers through public health expense calculations and the commission's pricing rules.
HB 120 appropriates $1,040,514 annually for fiscal years 2025-2026 and 2026-2027 to expand North Carolina's Project C.A.R.E. program. The bill directly funds support services for family caregivers of individuals living with Alzheimer's disease or related dementias. It provides recurring state funding to the Division of Aging and Adult Services to enhance existing caregiver assistance programs. The legislation becomes effective July 1, 2025, without altering eligibility or service requirements.
HB 229 adjusts North Carolina's Medicaid reimbursement rates for ambulatory surgical centers (ASCs), requiring payments to be at least 95% of the current Medicare Ambulatory Surgical Centers fee schedule. This change directly affects ASCs by increasing their Medicaid payments, with the state appropriating $10.476 million annually from the General Fund to cover the cost and match $19.135 million in federal funds each year for the 2025-2027 fiscal biennium. The bill mandates these rate adjustments to take effect on July 1, 2025, ensuring ASCs receive consistent reimbursement aligned with Medicare rates. The legislation focuses solely on establishing the new payment structure and funding mechanism, without altering eligibility or services.
SB 139 prevents the elimination of medical benefits for North Carolina state teachers and employees who first earned retirement service on or after January 1, 2021. It reverses a prior change that would have cut these benefits by repealing specific sections of law, effective retroactively to December 31, 2020. The bill appropriates $500,000 annually for 2025-2026 and $2 million annually for 2026-2027 to cover increased costs for the state health plan. This restores medical coverage for affected retirees under several retirement systems, effective July 1, 2025.
HB 60 increases Medicaid dental reimbursement rates from 35% to 46% of average dentist charges (2023 rates) to align with neighboring states. The bill allocates $52 million annually from North Carolina's General Fund, matched by $95 million in federal funds, to cover this rate increase starting July 1, 2025. It directly affects dentists who accept Medicaid patients and Medicaid beneficiaries seeking dental care, aiming to boost provider participation and prevent costly emergency treatments. The change addresses years of stagnant rates that reduced dental provider enrollment in Medicaid.
